Back to Markets
Stocks● Neutral
CMA Approves Dallah Healthcare 20% Bonus Share Capital Increase
Saudi CMA approved Dallah Healthcare's capital increase to SAR 1.22B via 20% bonus shares. The move adds 20M shares, improving float and institutional access without new cash.
Continue with
Saudi Arabia's Capital Market Authority approved Dallah Healthcare Co.'s capital increase to SAR 1.22 billion from SAR 1.02 billion. The company will issue roughly 20 million new shares as a 20% bonus issue, funded from retained earnings.
Bonus shares do not bring new cash into the business. The market capitalization stays the same because the stock price adjusts downward by the dilution factor. What changes is the float. A 20% larger share count means more shares available for trading. That can widen the shareholder base and improve the stock's weighting in Tadawul's main market index.
The approval arrives during a quiet period for Saudi healthcare stocks. The sector has delivered mixed returns in 2025. Operators with heavy government contract exposure have held up better than those relying on private-pay volume. Dallah sits in the middle, with a blend of ministry work and direct patient revenue across its hospital network.